• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺泡巨噬细胞和腹腔巨噬细胞对可吸入微球吞噬作用的抑制。

The inhibition of phagocytosis of respirable microspheres by alveolar and peritoneal macrophages.

作者信息

Jones B G, Dickinson P A, Gumbleton M, Kellaway I W

机构信息

The Welsh School of Pharmacy, University of Wales, CF10 3XF, Cardiff, UK.

出版信息

Int J Pharm. 2002 Apr 2;236(1-2):65-79. doi: 10.1016/s0378-5173(02)00016-9.

DOI:10.1016/s0378-5173(02)00016-9
PMID:11891071
Abstract

Respirable poly(lactic co-glycolic acid) (PLGA) microspheres (2-3 microm diameter), were fabricated as a model drug delivery system whose uptake by macrophages could be quantified by fluorescent activated cell sorting. The microspheres exhibited minimal release of the entrapped flourophore (rhodamine B) and thus avoided possible fluid phase uptake of the flourophore. Externally bound microspheres were removed from the cell membrane by acid washing. The fluorescent intensity associated with the cells arose, therefore, from the internalised microspheres. NR8383 continuous culture alveolar macrophages were verified against primary cultures as a good model of alveolar phagocytosis. Peritoneal macrophages were also isolated and systemic and alveolar phagocytosis compared. Poloxamer 338 adsorbed at the microsphere surface did not reduce phagocytosis by NR8383 macrophages. It did, however, reduce the number of microspheres contained in primary alveolar macrophages but did not reduce the percentage of phagocytic cells. Poloxamer coatings did not reduce phagocytosis by peritoneal macrophages once the ratio of five microspheres per cell was exceeded. Dipalmitoylphosphatidylcholine (DPPC), the major component of lung surfactant, was added to cultures to model the alveolar environment where it was observed to reduce phagocytosis. In light of this finding, microspheres were coated in DPPC, which reduced their uptake by all cell types at all microsphere to cell ratios.

摘要

可吸入的聚乳酸-羟基乙酸共聚物(PLGA)微球(直径2-3微米)被制备为一种模型药物递送系统,其被巨噬细胞摄取的情况可通过荧光激活细胞分选进行定量分析。这些微球对包裹的荧光团(罗丹明B)释放极少,从而避免了荧光团可能的液相摄取。通过酸洗从细胞膜上去除外部结合的微球。因此,与细胞相关的荧光强度来自内化的微球。NR8383连续培养肺泡巨噬细胞经原代培养验证是肺泡吞噬作用的良好模型。还分离了腹膜巨噬细胞,并比较了全身和肺泡吞噬作用。吸附在微球表面的泊洛沙姆338不会降低NR8383巨噬细胞的吞噬作用。然而,它确实减少了原代肺泡巨噬细胞中所含微球的数量,但没有降低吞噬细胞的百分比。一旦每个细胞的微球比例超过五个,泊洛沙姆涂层不会降低腹膜巨噬细胞的吞噬作用。肺表面活性剂的主要成分二棕榈酰磷脂酰胆碱(DPPC)被添加到培养物中以模拟肺泡环境,在该环境中观察到它会降低吞噬作用。鉴于这一发现,微球用DPPC包被,这在所有微球与细胞比例下都降低了所有细胞类型对它们的摄取。

相似文献

1
The inhibition of phagocytosis of respirable microspheres by alveolar and peritoneal macrophages.肺泡巨噬细胞和腹腔巨噬细胞对可吸入微球吞噬作用的抑制。
Int J Pharm. 2002 Apr 2;236(1-2):65-79. doi: 10.1016/s0378-5173(02)00016-9.
2
Relating the phagocytosis of microparticles by alveolar macrophages to surface chemistry: the effect of 1,2-dipalmitoylphosphatidylcholine.肺泡巨噬细胞对微粒的吞噬作用与表面化学的关系:1,2-二棕榈酰磷脂酰胆碱的影响
J Control Release. 1998 Feb 12;51(2-3):143-52. doi: 10.1016/s0168-3659(97)00149-1.
3
Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages.肺泡巨噬细胞对载利福平PLGA微球进行高效吞噬作用的最佳条件。
J Control Release. 2007 May 14;119(1):69-76. doi: 10.1016/j.jconrel.2007.01.013. Epub 2007 Feb 1.
4
Lung surfactant phospholipids inhibit the uptake of respirable microspheres by the alveolar macrophage NR8383.肺表面活性物质磷脂可抑制肺泡巨噬细胞NR8383对可吸入微球的摄取。
J Pharm Pharmacol. 2002 Aug;54(8):1065-72. doi: 10.1211/002235702320266217.
5
PLGA microspheres phagocytosis by pig alveolar macrophages: influence of poly(vinyl alcohol) concentration, nature of loaded-protein and copolymer nature.猪肺泡巨噬细胞对聚乳酸-羟基乙酸共聚物微球的吞噬作用:聚乙烯醇浓度、负载蛋白性质及共聚物性质的影响
J Drug Target. 2000;7(5):343-54. doi: 10.3109/10611869909085517.
6
Phagocytic activity of alveolar macrophages toward polystyrene latex microspheres and PLGA microspheres loaded with anti-tuberculosis agent.肺泡巨噬细胞对聚苯乙烯乳胶微球及负载抗结核药物的聚乳酸-羟基乙酸共聚物微球的吞噬活性。
Colloids Surf B Biointerfaces. 2007 Nov 15;60(2):221-8. doi: 10.1016/j.colsurfb.2007.06.017. Epub 2007 Jun 21.
7
Flow cytometric and optical microscopic evaluation of poly(D, L-lactide-co-glycolide) microspheres phagocytosis by pig alveolar macrophages.
J Control Release. 1999 Apr 19;58(3):289-301. doi: 10.1016/s0168-3659(98)00166-7.
8
A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.一种基于聚(乳酸-乙醇酸共聚物)微球和聚乙烯醇水凝胶纳米颗粒的异质结构复合材料,用于长期蛋白质药物递送。
Pharm Res. 1999 Sep;16(9):1430-5. doi: 10.1023/a:1018911411381.
9
Phagostimulatory effect of uptake of PLGA microspheres loaded with rifampicin on alveolar macrophages.载利福平 PLGA 微球被肺泡巨噬细胞摄取的趋化刺激作用。
Colloids Surf B Biointerfaces. 2011 Oct 15;87(2):293-8. doi: 10.1016/j.colsurfb.2011.05.032. Epub 2011 May 26.
10
A novel system based on a poloxamer/PLGA blend as a tetanus toxoid delivery vehicle.一种基于泊洛沙姆/聚乳酸-羟基乙酸共聚物共混物作为破伤风类毒素递送载体的新型系统。
Pharm Res. 1999 May;16(5):682-8. doi: 10.1023/a:1018820507379.

引用本文的文献

1
Development and characterization of lung surfactant-coated polymer nanoparticles for pulmonary drug delivery.肺表面活性剂包裹聚合物纳米粒的制备及特性研究——用于肺部药物递送。
Biomater Adv. 2023 Jul;150:213430. doi: 10.1016/j.bioadv.2023.213430. Epub 2023 Apr 21.
2
Developing inhaled protein therapeutics for lung diseases.开发用于肺部疾病的吸入性蛋白质疗法。
Mol Biomed. 2020;1(1):11. doi: 10.1186/s43556-020-00014-z. Epub 2020 Oct 30.
3
Large Porous Hollow Particles: Lightweight Champions of Pulmonary Drug Delivery.大孔空心颗粒:肺部药物递送的轻质冠军。
Curr Pharm Des. 2016;22(17):2463-9. doi: 10.2174/1381612822666160128145356.
4
Nano-sized and micro-sized polystyrene particles affect phagocyte function.纳米级和微米级聚苯乙烯颗粒会影响吞噬细胞功能。
Cell Biol Toxicol. 2014 Feb;30(1):1-16. doi: 10.1007/s10565-013-9265-y. Epub 2013 Nov 29.
5
Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols.设计、物理化学特性分析和优化有机溶液高级喷雾干燥二棕榈酰磷脂酰胆碱(DPPC)和二棕榈酰磷脂酰乙醇胺聚乙二醇(DPPE-PEG)微米和纳米粒子,用于作为干粉吸入剂气溶胶的靶向呼吸纳米医学递药。
Int J Nanomedicine. 2013;8:275-93. doi: 10.2147/IJN.S30724. Epub 2013 Jan 15.
6
The cannabinoid WIN55,212-2 protects against oxidized LDL-induced inflammatory response in murine macrophages.大麻素 WIN55,212-2 可防止氧化型 LDL 诱导的小鼠巨噬细胞炎症反应。
J Lipid Res. 2010 Aug;51(8):2181-90. doi: 10.1194/jlr.M001511. Epub 2010 Mar 20.
7
PLGA microparticles in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen TB10.4-Ag85B.可吸入尺寸的 PLGA 微球增强了对重组结核分枝杆菌抗原 TB10.4-Ag85B 的体外 T 细胞反应。
Pharm Res. 2010 Feb;27(2):350-60. doi: 10.1007/s11095-009-0028-7. Epub 2009 Dec 19.
8
Stimulation of phagocytic activity of alveolar macrophages toward artificial microspheres by infection with mycobacteria.分枝杆菌感染对肺泡巨噬细胞吞噬人工微球活性的刺激作用。
Pharm Res. 2008 Jun;25(6):1420-30. doi: 10.1007/s11095-007-9525-8.
9
Poly (lactide-co-glycolide) microspheres in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen 85B.可吸入尺寸的聚(丙交酯-共-乙交酯)微球增强了体外T细胞对重组结核分枝杆菌抗原85B的反应。
Pharm Res. 2007 Oct;24(10):1834-43. doi: 10.1007/s11095-007-9302-8. Epub 2007 Jul 27.
10
Carrier-based strategies for targeting protein and peptide drugs to the lungs.将蛋白质和肽类药物靶向输送至肺部的基于载体的策略。
AAPS J. 2005 Mar 24;7(1):E20-41. doi: 10.1208/aapsj070104.